New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

Samuel J. Gesten net worth and biography

Samuel Gesten Biography and Net Worth

Insider of STAAR Surgical

Mr. Gesten joined STAAR in April 2012 as Vice President, General Counsel and Secretary. In May 2014, he assumed the role Vice President of Business Development and Chief Legal Officer. In addition to his roles as Chief Legal Officer and Secretary, Mr. Gesten serves as Chief Compliance Officer. From 2009 through 2011, he served as Executive Vice President, General Counsel and as a member of the Executive Committee of Allergan, Inc. Prior to that, he spent 11 years at Thermo Fisher Scientific Inc. in a variety of positions, including General Counsel and Assistant Secretary of the Laboratory Products Group and Vice President, Deputy General Counsel. Prior to his work at Thermo Fisher, Mr. Gesten spent 11 years practicing law. He holds a B.A. in Economics from Brandeis University and a J.D. from Boston University.

What is Samuel J. Gesten's net worth?: The estimated net worth of Samuel J. Gesten is at least $1.12 million as of March 22nd, 2021. Mr. Gesten owns 42,583 shares of STAAR Surgical stock worth more than $1,120,785 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Gesten may own. Learn More about Samuel J. Gesten's net worth.
How do I contact Samuel J. Gesten?: The corporate mailing address for Mr. Gesten and other STAAR Surgical executives is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. STAAR Surgical can also be reached via phone at (626) 303-7902 and via email at [email protected]. Learn More on Samuel J. Gesten's contact information.
Has Samuel J. Gesten been buying or selling shares of STAAR Surgical?: Samuel J. Gesten has not been actively trading shares of STAAR Surgical during the last ninety days. Most recently, Samuel J. Gesten sold 15,000 shares of the business's stock in a transaction on Monday, October 4th. The shares were sold at an average price of $114.53, for a transaction totalling $1,717,950.00. Learn More on Samuel J. Gesten's trading history.
Who are STAAR Surgical's active insiders?: STAAR Surgical's insider roster includes Hans-Martin Blickensdoerfer (VP), James Francese (VP), Samuel Gesten (Insider), Graydon Hansen (VP), Jon Hayashida (VP), Keith Holliday (CTO), Caren Mason (CEO), and Patrick Williams (CFO). Learn More on STAAR Surgical's active insiders.
Are insiders buying or selling shares of STAAR Surgical?: During the last twelve months, STAAR Surgical insiders bought shares 8 times. They purchased a total of 445,106 shares worth more than $13,552,706.08. The most recent insider tranaction occured on August, 12th when Director Arthur C Butcher bought 1,315 shares worth more than $49,956.85. Insiders at STAAR Surgical own 1.0% of the company. Learn More about insider trades at STAAR Surgical.
Information on this page was last updated on 8/12/2024.

Samuel J. Gesten Insider Trading History at STAAR Surgical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/4/2021	Sell	15,000	$114.53	$1,717,950.00
3/22/2021	Sell	1,032	$96.37	$99,453.84	42,583
5/21/2020	Sell	192,522	$40.00	$7,700,880.00	61,185
3/23/2020	Sell	2,742	$27.42	$75,185.64	42,873
3/22/2019	Sell	1,688	$38.87	$65,612.56	36,816
3/19/2019	Sell	1,500	$36.20	$54,300.00	36,816
3/22/2018	Sell	2,833	$16.05	$45,469.65	38,316
4/6/2015	Sell	3,223	$7.14	$23,012.22

Samuel J. Gesten Buying and Selling Activity at STAAR Surgical

STAAR Surgical Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Today's Range

Now: $26.71

$25.93

$26.82

50 Day Range

MA: $31.06

$26.14

$37.23

2 Week Range

Now: $26.71

$25.88

$52.68

Volume

153,983 shs

Average Volume

710,915 shs

Market Capitalization

$1.32 billion

P/E Ratio

60.70

Dividend Yield

N/A

Beta

0.61

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide